Genesee Capital Advisors’s Arch Capital ACGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,962
Closed -$874K 115
2023
Q3
$874K Hold
10,962
0.63% 44
2023
Q2
$821K Hold
10,962
0.56% 49
2023
Q1
$744K Hold
10,962
0.53% 50
2022
Q4
$688K Hold
10,962
0.51% 48
2022
Q3
$499K Sell
10,962
-2,500
-19% -$113K 0.38% 56
2022
Q2
$612K Hold
13,462
0.43% 57
2022
Q1
$652K Hold
13,462
0.34% 67
2021
Q4
$598K Hold
13,462
0.29% 67
2021
Q3
$514K Buy
+13,462
New +$533K 0.25% 74
2021
Q2
Sell
-13,462
Closed -$517K 46
2021
Q1
$517K Hold
13,462
0.31% 63
2020
Q4
$485K Hold
13,462
0.32% 59
2020
Q3
$393K Buy
13,462
+2,250
+20% +$68.6K 0.32% 54
2020
Q2
$321K Hold
11,212
0.3% 60
2020
Q1
$319K Buy
11,212
+650
+6% +$26.3K 0.31% 61
2019
Q4
$453K Hold
10,562
0.39% 55
2019
Q3
$443K Hold
10,562
0.41% 56
2019
Q2
$391K Buy
+10,562
New +$360K 0.39% 57

Other funds holding ACGL

Genesee Capital Advisors's ACGL Position: Q4 2023 in Review

Genesee Capital Advisors sold out of Arch Capital (ACGL) in Q4 2023, closing a stake of 10,962 shares — an estimated $874K sold.

Genesee Capital Advisors first reported a position in ACGL in Q2 2019 and held it in 17 quarters. The position peaked at $874K in Q3 2023. 765 funds tracked by Wall St. Rank hold ACGL as of Q4 2023.

  • Genesee Capital Advisors reported no remaining Arch Capital position as of Q4 2023 after selling out during the quarter.
  • Genesee Capital Advisors sold 10,962 Arch Capital shares in Q4 2023, an estimated $874K.
  • Genesee Capital Advisors first reported a position in Arch Capital in Q2 2019 and held it in 17 quarters.
  • Genesee Capital Advisors's Arch Capital position peaked at $874K in Q3 2023.
  • 765 funds tracked by Wall St. Rank held Arch Capital as of Q4 2023.

Based on Genesee Capital Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.